Neutrophil percentage to albumin ratio and advanced cardiovascular-kidney-metabolic syndrome in diabetes: a machine learning approach.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: NHANES data from 9,375 adults were analyzed for NPAR/advanced CKM association; Boruta-based feature selection and an ML model predicted advanced CKM (validation AUC 0.872), a retrospective association/prediction result.
Technology: BackgroundDiabetes mellitus (DM) has become an increasingly significant global health challenge, with rising complications and mortality rates. Patients with DM are at a higher risk for advanced Cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the importance of early detection and precise prevention strategies. The neutrophil percentage to albumin ratio (NPAR), a composite biomarker, may be indicative of inflammatory dysregulation and nutritional status in patients with advanced…
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Using six NHANES cycles, the study assessed the association between neutrophil percentage-to-albumin ratio and advanced CKM syndrome, then used Boruta feature selection and machine learning for internal prediction.
- Limitation / still unknown
- The full text describes the cohort or experimental system, comparison/reference, and internal/external or experimental validation used for the represented claim; no broader clinical benefit is inferred.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12720478/ · https://europepmc.org/article/MED/41310885
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.